PM urges vaccine manufacturers to scale production capacity

The country has constantly worked with the spirit of public-private partnership

Covaxin vaccine production to increase 7x by August 2021

The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021.

Piramal Pharma Solutions boosts formulation development at Morpeth site with Korsch XM-12

Sai Life Sciences opens dedicated facility for veterinary APIs in Bidar

Merck opens €150 million manufacturing facility in Ireland

Merck opens first climate-neutral manufacturing facility in Ireland

Novo Nordisk’s Wegovy delivered 16.6% weight loss

Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight

Lilly to build $5 billion manufacturing facility in Virginia

This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year

ProBioGen to spearhead GMP manufacturing at Berlin’s gene & cell therapy hub

ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit

Mycenax and Spera forge alliance to streamline ADC drug substance

Fermenta granted process patent for plant-based Vitamin D3